Edwards Lifesciences Corp earnings per share and revenue
On Oct 30, 2025, EW reported earnings of 0.67 USD per share (EPS) for Q3 25, beating the estimate of 0.61 USD, resulting in a 9.62% surprise. Revenue reached 1.55 billion, compared to an expected 1.54 billion, with a 0.84% difference. The market reacted with a -1.23% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 31 analysts forecast an EPS of 0.63 USD, with revenue projected to reach 1.59 billion USD, implying an decrease of -5.97% EPS, and increase of 2.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
FAQ
What were Edwards Lifesciences Corp's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Edwards Lifesciences Corp reported EPS of $0.67, beating estimates by 9.62%, and revenue of $1.55B, 0.84% above expectations.
How did the market react to Edwards Lifesciences Corp's Q3 2025 earnings?
The stock price moved down -1.23%, changed from $83.48 before the earnings release to $82.45 the day after.
When is Edwards Lifesciences Corp expected to report next?
The next earning report is scheduled for Feb 10, 2026.
What are the forecasts for Edwards Lifesciences Corp's next earnings report?
Based on 31
analysts, Edwards Lifesciences Corp is expected to report EPS of $0.63 and revenue of $1.59B for Q4 2025.